York Capital Management Global Advisors LLC raised its stake in shares of Humana Inc. (NYSE:HUM) by 119.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 394,115 shares of the insurance provider’s stock after purchasing an additional 214,712 shares during the period. Humana accounts for 2.0% of York Capital Management Global Advisors LLC’s holdings, making the stock its 12th biggest position. York Capital Management Global Advisors LLC owned about 0.27% of Humana worth $94,832,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. BlackRock Inc. raised its position in shares of Humana by 2,281.7% in the first quarter. BlackRock Inc. now owns 12,387,144 shares of the insurance provider’s stock valued at $2,553,487,000 after buying an additional 11,867,056 shares during the last quarter. FMR LLC raised its position in shares of Humana by 57.9% in the first quarter. FMR LLC now owns 5,050,853 shares of the insurance provider’s stock valued at $1,041,184,000 after buying an additional 1,851,197 shares during the last quarter. Janus Henderson Group PLC raised its position in shares of Humana by 7,848.8% in the second quarter. Janus Henderson Group PLC now owns 1,567,587 shares of the insurance provider’s stock valued at $377,192,000 after buying an additional 1,547,866 shares during the last quarter. Renaissance Technologies LLC raised its position in shares of Humana by 84.3% in the first quarter. Renaissance Technologies LLC now owns 2,691,700 shares of the insurance provider’s stock valued at $554,867,000 after buying an additional 1,231,400 shares during the last quarter. Finally, Wellington Management Group LLP raised its position in shares of Humana by 2,651.1% in the first quarter. Wellington Management Group LLP now owns 775,755 shares of the insurance provider’s stock valued at $159,915,000 after buying an additional 747,557 shares during the last quarter. 95.12% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another website, it was illegally copied and reposted in violation of United States & international copyright and trademark law. The legal version of this report can be read at https://www.thecerbatgem.com/2017/10/06/humana-inc-hum-holdings-boosted-by-york-capital-management-global-advisors-llc.html.

In other Humana news, insider Elizabeth D. Bierbower sold 9,786 shares of the firm’s stock in a transaction dated Friday, September 1st. The stock was sold at an average price of $259.00, for a total transaction of $2,534,574.00. Following the completion of the sale, the insider now directly owns 18,042 shares in the company, valued at approximately $4,672,878. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider William Kevin Fleming sold 3,071 shares of the firm’s stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $250.98, for a total value of $770,759.58. Following the sale, the insider now owns 7,681 shares of the company’s stock, valued at $1,927,777.38. The disclosure for this sale can be found here. Insiders have sold a total of 55,595 shares of company stock valued at $14,133,706 over the last 90 days. Corporate insiders own 0.80% of the company’s stock.

Several equities research analysts recently issued reports on HUM shares. Citigroup Inc. started coverage on shares of Humana in a research report on Wednesday, June 28th. They set a “buy” rating and a $275.00 price objective for the company. ValuEngine upgraded shares of Humana from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. BidaskClub cut shares of Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, July 19th. Argus upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $260.00 price target for the company in a research report on Friday, June 9th. Finally, Bank of America Corporation lifted their price target on shares of Humana from $270.00 to $275.00 and gave the company a “buy” rating in a research report on Friday, July 14th. Nine equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $247.50.

Humana Inc. (NYSE HUM) traded up 0.8844% on Friday, reaching $247.5299. 328,147 shares of the company’s stock were exchanged. The stock has a market capitalization of $35.77 billion, a P/E ratio of 20.3628 and a beta of 0.86. The firm’s 50 day moving average is $249.11 and its 200 day moving average is $234.09. Humana Inc. has a 1-year low of $163.50 and a 1-year high of $259.76.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The business had revenue of $13.53 billion during the quarter, compared to analyst estimates of $13.61 billion. During the same quarter last year, the company posted $2.30 EPS. Analysts expect that Humana Inc. will post $11.55 EPS for the current year.

The firm also recently disclosed a dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 29th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s payout ratio is presently 13.06%.

Humana Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.